23.27
Schlusskurs vom Vortag:
$22.86
Offen:
$23.15
24-Stunden-Volumen:
259.09K
Relative Volume:
0.31
Marktkapitalisierung:
$2.84B
Einnahmen:
$1.72B
Nettoeinkommen (Verlust:
$12.82M
KGV:
232.75
EPS:
0.1
Netto-Cashflow:
$98.59M
1W Leistung:
-5.08%
1M Leistung:
+0.45%
6M Leistung:
+7.45%
1J Leistung:
+34.45%
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PRVA
Privia Health Group Inc
|
23.28 | 3.05B | 1.72B | 12.82M | 98.59M | 0.10 |
![]()
VEEV
Veeva Systems Inc
|
238.37 | 39.05B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
TEM
Tempus Ai Inc
|
64.70 | 11.03B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
101.10 | 8.46B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
DOCS
Doximity Inc
|
51.84 | 10.10B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
39.19 | 6.85B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-10 | Eingeleitet | Needham | Buy |
2024-12-16 | Eingeleitet | Macquarie | Outperform |
2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
2024-04-22 | Eingeleitet | Citigroup | Buy |
2024-03-06 | Eingeleitet | Barclays | Equal Weight |
2024-02-26 | Fortgesetzt | Jefferies | Buy |
2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
2023-04-12 | Eingeleitet | Stephens | Overweight |
2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-02-03 | Eingeleitet | Goldman | Buy |
2022-12-09 | Eingeleitet | Stifel | Buy |
2022-12-08 | Eingeleitet | UBS | Buy |
2022-09-07 | Fortgesetzt | Truist | Buy |
2022-05-03 | Eingeleitet | BofA Securities | Buy |
2022-04-28 | Eingeleitet | BTIG Research | Buy |
2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
2022-03-30 | Eingeleitet | Guggenheim | Buy |
2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
2022-01-03 | Eingeleitet | Jefferies | Buy |
2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
2021-09-10 | Eingeleitet | Cowen | Market Perform |
2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
2021-05-24 | Eingeleitet | JP Morgan | Overweight |
2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
2021-05-24 | Eingeleitet | Truist | Buy |
2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Ameriprise Financial Inc. - Defense World
(PRVA) Long Term Investment Analysis - news.stocktradersdaily.com
Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com
Cetera Investment Advisers Reduces Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group Approves Key Proposals at Meeting - TipRanks
Bank of America Corp DE Has $19.98 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Investing in Smarter Healthcare: The New Era of AI-Driven Medicine - The Globe and Mail
Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks - Yahoo Finance
Some May Be Optimistic About Privia Health Group's (NASDAQ:PRVA) Earnings - Yahoo Finance
Top Executives Cash In on Privia Health Group Stock - TipRanks
How the (PRVA) price action is used to our Advantage - news.stocktradersdaily.com
The Manufacturers Life Insurance Company Trims Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Privia Health’s Earnings Call Highlights Growth and Challenges - TipRanks
Privia Health Group’s Strong Performance and Strategic Expansion Drive Positive Outlook - TipRanks
Has Privia Health Group, Inc.'s (NASDAQ:PRVA) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st
Tower Research Capital LLC TRC Sells 799 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Truist Securities Adjusts Price Target on Privia Health Group to $30 From $28, Maintains Buy Rating - marketscreener.com
Privia Health Q1 2025 slides: Strong growth and margin expansion fuel raised guidance - Investing.com
Privia Health: Q1 Earnings Snapshot - New Haven Register
Privia Health Group Inc (PRVA) Q1 2025 Earnings Call Highlights: Strong Growth and Strategic ... By GuruFocus - Investing.com Canada
Privia Health Reports Strong Q1 2025 Results - TipRanks
Privia Health Group: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Privia Health Group: Strong Financial Performance and Strategic Growth Positioning Justify Buy Rating - TipRanks
Privia Health Group Q1 2025 Earnings Call Transcript - MarketBeat
Privia Health Q1 2025 slides: Strong growth and margin expansion fuel raised guidance By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health beats Q1 2025 expectations - Investing.com
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call transcript: Privia Health beats Q1 2025 expectations By Investing.com - Investing.com UK
Privia Health Group, Inc. SEC 10-Q Report - TradingView
Privia Health Group's Q1 Non-GAAP Earnings, Revenue Rise - marketscreener.com
Privia Health (PRVA) Misses Q1 Earnings Estimates - Yahoo Finance
Privia Health beats Q1 estimates, raises full-year outlook By Investing.com - Investing.com Nigeria
Privia Health beats Q1 estimates, raises full-year outlook - Investing.com Australia
Privia Health (NASDAQ:PRVA) Exceeds Q1 Expectations - Yahoo Finance
Privia Health Reports First Quarter 2025 Financial Results - The Manila Times
Earnings Flash (PRVA) Privia Health Group Reports Q1 Revenue $480.1M, vs. FactSet Est of $452.8M - marketscreener.com
Privia Health Reports First Quarter 2025 Financial Results - GlobeNewswire Inc.
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Privia Health (PRVA) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Where are the Opportunities in (PRVA) - news.stocktradersdaily.com
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):